Skip to main content
. 2017 Jan 30;13(3):1641–1646. doi: 10.3892/ol.2017.5659

Figure 2.

Figure 2.

Immunohistochemical staining of estrogen receptor β (ERβ) before and after chemotherapy in breast carcinoma tissues. (A) Before chemotherapy; (B) after chemotherapy of the same patient, staining of the breast carcinoma (ductal carcinoma) tissues immunohistochemically (magnification, ×200) after the neoadjuvant chemotherapy; (C) the ERβ expression level in the breast carcinoma tissues of the patient is significantly decreased, showing statistical significance (P<0.05).